Cyprotex
About:
Cyprotex is a contract research organization specialized in preclinical absorption, distribution, metabolism, and excretion (ADME).
Website: http://cyprotex.com
Twitter/X: cyprotexplc
Description:
Cyprotex specialises in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling). Cyprotex was founded in 1999, and in 2002 it was listed on the London Stock Exchange’s AIM Market (symbol CRX, information for investors). Our headquarters are in Macclesfield, UK, near Manchester.
Total Funding Amount:
$2.68M
Headquarters Location:
Macclesfield, Cheshire East, United Kingdom
Founded Date:
1999-01-01
Contact Email:
enquiries(AT)cyprotex.com
Founders:
David Leahy
Number of Employees:
51-100
Last Funding Date:
2010-08-17
IPO Status:
Delisted
Industries:
© 2025 bioDAO.ai